Solid forms of (2S, 3R, 4R, 5S, 6R) - 2 - (4 - chlorine - 3 - (4 - etoxibenzil) phenyl) - 6 - (methylthio) tetrahydro-2h-pyran - 3,4,5 - triol

摘要

Refers to a Crystalline Compound (2S, 3R, 4R, 5S, 6R) - 2 - (4 - chlorine - 3 - (4 - etoxibenzil) phenyl) - 6 - (methylthio) tetrahydro-2h-pyran - 3,4,5 - triol anhydrous Amorphous characterized with DSC endoterma is close to 124 degrees; an x-ray diffraction pattern with one or more Maximum 4.0 8.1 9.8, 14.0 - Theta - and / or 19.3 degrees 2.It also relates to a preparation method for a Solid Pharmaceutical Form. This Compound is an inhibitor of SGL T2, being useful in the treatment of Metabolic Disorders such as type I and II diabetes, atherosclerosis, obesity, among others